Effect of immunomodulator dzherelo on CD4 + T-lymphocyte counts and viral load in HIV infected patients receiving anti-retroviral therapy

Research Journal of Pharmacology

Volumn 2, Issue 1, 2008, Pages 8-12

  Nikolaeva, Lyudmila G ^a   Maystat, Tatyana V ^a   Pylypchuk, Volodymyr S ^b   Volyanskii, Yuri L ^c   Kutsyna, Galyna A ^d  

^a KHARKIV MEDICAL ACADEMY OF POSTGRADUATE EDUCATION   (Ukraine)

^b Ekomed LLC   (Ukraine)

^c National Academy of Medical Sciences of Ukraine   (Ukraine)

^d Luhansk Regional AIDS Center   (Ukraine)

Author keywords

AIDS; Antiviral; ART; HAART; Immunotherapy; Phytotherapy

Indexed keywords

DZHERELO; EFAVIRENZ; IMMUNOMODULATING AGENT; LAMIVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL PARAMETERS; IMMUNOMODULATION; IMMUNOPHENOTYPING; LYMPHOCYTE SUBPOPULATION; MALE; NONHUMAN; PHASE 2 CLINICAL TRIAL; POLYMERASE CHAIN REACTION; RANDOMIZED CONTROLLED TRIAL; VIRUS LOAD;

EID: 65649120259     PISSN: 18159362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Appay, V., F. Boutboul and B. Autran, 2003. The HIV infection and immune activation: To fight and burn. Curr. Infect. Dis. Rep., 7: 473-479.
2. Arduino, J.M., M.A. Fischl, K. Stanley, A.C. Collier and D. Spiegelman, 2001. Do HIV type 1 RNA levels provide additional prognostic value to CD4(+) T lymphocyte counts in patients with advanced HIV type 1 infection? AIDS Res. Hum. Retroviruses, 17: 1099-105.
3. Bogner, J.R. and F.D. Goebel, 1991. Lymphocyte subsets as surrogate markers in antiretroviral therapy. Infection, 19: 103-108.
4. Chehitiany, R., V. Pylipchuk, O. Argzanova, N. Prihoda, I. Vihrova, E. Zagaidanova and G. Kutsyna, 2006. Influence of an agent with immunomodulating activities, Dzherelo, on immune response and metabolic parameters in combination therapy with NRTI+NNRTI and as a monotherapy in untreated HIV-infected individuals. Probl. Ecol. Med. Gen. Clin. Immunol., 71-72: 307-318.
5. Chkhetiany, R., V. Pylipchuk, O. Argzanova, N. Prihoda, L. Vihrova, E. Zagaynova and G. Kutsyna, 2007. Comparative effect of an immunomodulator Immunoxel (Dzherelo) when used alone or in combination with antiretroviral therapy in drug-naïve HIV infected individuals. Int. J. Biotechnol., 9: 267-276.
6. Dybul, M., A.S. Fauci, J.G. Bartlett J.E. Kaplan and A.K. Pau, 2002. Panel on Clinical Practices for Treatment of HIV. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Ann. Int. Med., 137: 381-433.
7. Ershov, F.I., 2003. Use of immunomodulators in viral infections. Antibiot Khimioter, 48: 27-32.
8. Kelly, J.A. and Y.A. Amirkhanian, 2003. The newest epidemic: A review of HIV/AIDS in Central and Eastern Europe. Int. J. STD AIDS, 14: 361-71.
9. Kutsyna, G., R. Chechitiany, I. Bascacov, E. Zagaydanova and I. Zaharova, 2005. Influence of a novel immunomodulator on the prevalence of new events of opportunistic infections in untreated HIV-infected individuals. 3rd European HIV Drug Resistance Workshop. Athens, Greece., 4-7. Abst 36.
10. Mocroft, A., A.N. Phillips, J. Gatell, B. Ledergerber, M. Fisher, N. Clumeck, M. Losso, A. Lazzarin, G. Fatkenheuer and J.D. Lundgren, 2007. EuroSIDA study group. Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: An observational cohort study. Lancet 370: 407-13.
11. Pokrovskii, V.V., 2001. Treatment of HIV-infections: Success or crisis?. Ter. Arkh, 73: 52-54.
12. Prihoda, N.D., O.V. Arjanova, N.I. Sokolenko and L.A. Vibrova, 2006. Clinical efficacy of phyto preparation Dzherelo in patients with co-morbid pathology: Pulmonary tuberculosis in combination with HIV infection. Probl. Ecol. Med. Gen. Clin. Immunol., 71-72: 151-161.
13. Van der Werf, M.J., O.B. Yegorova, N. Chentsova, Y. Chechulin, E. Hasker, V.I. Petrenko, J. Veen and L. V. Turchenko, 2006. Tuberculosis-HIV co-infection in Kiev City, Ukraine. Emerg. Infect. Dis., 12: 766-768.
14. Zaitseva, S.I., 2006. Clinical efficacy of phytopreparation Dzherelo and its influence on the functional status of liver in patients with destructive forms of tuberculosis. Probl. Ecol. Med. Gen. Clin. Immunol., 71-72: 132-140.